A Pilot Prospective Study of Refractory Solid Tumor Patients for NGS-Based Targeted Anticancer Therapy()()

With the advent of next-generation sequencing (NGS), targeted sequencing is now contributing to decision making for which chemotherapeutics to administer to cancer patients, especially in refractory and metastatic cancer. Given that most patients with refractory cancer develop resistance to chemothe...

Descripción completa

Detalles Bibliográficos
Autores principales: Seol, Young Mi, Kwon, Chae Hwa, Lee, So Jeong, Lee, Seon Jin, Choi, Yuri, Choi, Young Jin, Kim, Hyojeong, Park, Do Youn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2018
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6240710/
https://www.ncbi.nlm.nih.gov/pubmed/30448735
http://dx.doi.org/10.1016/j.tranon.2018.10.011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6240710/
https://www.ncbi.nlm.nih.gov/pubmed/30448735
http://dx.doi.org/10.1016/j.tranon.2018.10.011

Ejemplares similares